Calliditas Therapeutics AB (publ)

SSE:CALTX.ST

107.8 (SEK) • At close February 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) SEK.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q1
Operating Activities:
Net Income -47.478-203.826-18.368-159.573-75.172-187.52532.495-36.227-209.844-208.367-222.1337.856-159.398-150.781-135.941-104.891-66.562-72.326-18.043-52.63885.386-42.724-44.745-31.273-18.207-38.257-40.539-17.474-15.487-11.009
Depreciation & Amortization 0016.59400012.9130006.4580002.8230001.8220000.05100.01200.0130.0120.0130.013
Deferred Income Tax 000000-48.70400000000000000000000000
Stock Based Compensation 0052.59100035.79100021.960006.0120000.24900000000000
Change In Working Capital -32.40613.624-28.12260.163-49.564-62.218177.318-85.053-21.12917.28525.611-49.20817.31811.7495.529-2.875-1.4852.909-29.082135.007-141.949-6.7782.24716.04-18.4574.41213.8810.4593.443-1.602
Accounts Receivables 00-182.589000-91.878000-11.7120008.033000-53.5460002.642000-1.885000
Change In Inventory 00-16.781000-2.758000-0.9490000000000000000000
Change In Accounts Payables 000000000000000000000000000000
Other Working Capital -32.40613.624-28.12160.163-49.564-62.218271.954-85.053-21.12917.28538.272-49.20817.31811.749-2.504-2.875-1.4852.90924.464135.007-145.048-6.778-0.39516.04-18.4574.41215.7660.4593.443-1.602
Other Non Cash Items 72.84116.25969.33536.881-38.29517.80320.216-3.4455.739-0.34135.2688.1079.174.85310.3384.451.0260.6421.690.74-2.740.120.0120.010.0170.010.0080.290.010.013
Operating Cash Flow -7.043-198.20522.845-62.529-163.031-231.94230.029-124.725-225.234-191.423-161.254-33.245-132.91-134.179-120.074-103.316-67.016-18.775-45.43583.109-59.303-49.382-42.486-15.223-36.647-33.835-26.65-16.725-12.034-12.598
Investing Activities:
Investments In Property Plant And Equipment 7.0430-12.788000-2.512000-6.5880000000-0.11800000000000
Acquisitions Net 0000000000-39.0202.2820-172.602000000000000000
Purchases Of Investments 000000000000000000000000000000
Sales Maturities Of Investments 000000000000000000000000000000
Other Investing Activites -0.102-3.85811.392-7.417-1.06-2.9131.046-0.888-0.139-2.651-5.337-0.236-18.568-0.199-172.605-0.001-0.0010-0.291-15.775-2.00600000-0.05000
Investing Cash Flow -0.102-3.858-2.354-7.417-1.06-2.913-1.466-0.888-0.139-2.651-5.337-0.236-18.568-0.199-172.605-0.001-0.0010-0.291-15.775-2.00600000-0.05000
Financing Activities:
Debt Repayment -4.06-5.467-235.148-2.888-3.015-2.969-2.861-2.569-2.527-1.658-2.269-1.944-0.351-1.01-1.484-0.636-0.627-1.225-0.589-0.580000000000
Common Stock Issued 0.0140000031.47700.23661.7130.0013240-0.982063.38882800210.3170000029.9990000
Common Stock Repurchased 00000000-0.2360000000000000000-0.470000
Dividends Paid 000000000000000000000000000000
Other Financing Activities -4.060-26.625-2.888-3.015-2.969254.022-2.569238.39461.712-39.02164.739-0.366-8.617-77.847.434791.173-13.477-1.253200.355-0.138-0.1292.258684.1980.5780.00962.1063.08136.0370
Financing Cash Flow -4.046-5.467208.522-2.888-3.015-2.969282.638-2.569235.86760.054-41.289486.795-0.717-9.627-79.32470.186791.173-13.477-1.253200.355-0.138-0.1292.258684.1980.57829.53862.1063.08136.0370
Other Information:
Effect Of Forex Changes On Cash -1.84844.114-42.162-6.46419.6872.3271.73217.54510.8973.921-0.4321.198-5.84515.047-28.562-29.5696.8397.286-4.5562.523-0.540.1860.532-0.1270.0180.019-0.006-0.074-0.0540.078
Net Change In Cash -13.039-163.416186.85-79.298-147.419-235.494512.933-110.63821.391-130.099-208.312454.512-158.04-128.958-400.565-62.7730.995-24.966-51.535270.212-61.987-49.325-39.696668.848-36.051-4.27835.4-13.71823.949-12.52
Cash At End Of Period 797.278810.317973.733786.883866.1811,013.61,249.094736.161846.799825.408955.5071,163.818709.306867.346996.3041,396.8691,459.569728.574753.54805.075534.863596.85646.175685.87117.02353.07457.35221.95235.6711.721